Pune Hospital to Use New Drug Tocilizumab Worth Rs 20k for C
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
At least 25 COVID-19 patients, who are in a semi-critical condition at Pune's government-run Sassoon General Hospital, will be administered tocilizumab, a drug that has proven effective in treating the infection, an official said.

• The new drug, an injection that costs around Rs 20,000

• It will be given to 25 patients in the first phase and depending on the results, the Pune Municipal Corporation will decide on its further use, municipal commissioner Shekhar Gaikwad said.

• The task force has recommended the use of the drug in patients below 50 years of age, those with evidence of cytokine storm, requiring oxygen, and having a persistent fever.

• "Tocilizumab was administered to an Anganwadi worker, admitted to Bharti Hospital in a critical condition, who made a remarkable recovery," he said.

• "Civic hospitals in Mumbai were also using the drug to treat COVID-19 patients and it has given good results", he said.

Source: https://www.livemint.com/news/india/pune-hospital-to-use-new-drug-for-covid-19-treatment-11590138201443.html
Dr. N●●●●a S●●h and 14 others like this8 shares
Like
Comment
Share
Dr. P●●●●●●●●a S N●●k
Dr. P●●●●●●●●a S N●●k Occupational Medicine
Is it one of the Biologicals ? how many days does it take to act /to be effective? what are the untoward effects?
May 25, 2020Like1
Dr. S●●●●●m S●●●●y P●●●●●l
Dr. S●●●●●m S●●●●y P●●●●●l General Medicine
Well,well,this is very good news.
May 26, 2020Like
Dr. M●●●●●v D●●●i
Dr. M●●●●●v D●●●i Internal Medicine
Yes, Tocilizumab is a biologic drug, developed specifically as Interleukin-6 (IL-6) inhibitor. In Covid19, one of the subsets of patients suddenly develop ARDS because of cytokine storm because of release of IL-6. Tocilizumab has given excellent results in the right patient at the right time of the illness. I have witnessed best, good and no results in patients of many of our colleguages. Now that laboratory can carry out IL-6 in blood is an useful parameter in selecting the right patient and timing in correlation of clinical findings.... Read more
May 28, 2020Like